Cerebral and Extracranial Neurodegeneration in Parkinson’s Disease
Author Information
Author(s): Jörg Spiegel, Dirk Hellwig, Wolfgang H. Jost, Georgios Farmakis, Samuel Samnick, Klaus Fassbender, Carl M. Kirsch, Ulrich Dillmann
Primary Institution: Saarland University
Hypothesis
Are cerebral and extracranial Lewy body type-degeneration in Parkinson's disease coupled?
Conclusion
Cerebral and extracranial changes in Parkinson's disease are strongly coupled and driven by similar mechanisms.
Supporting Evidence
- At all Hoehn and Yahr stages, myocardial MIBG uptake correlated significantly with striatal FP-CIT uptake.
- 88 out of 95 patients showed reduced myocardial MIBG uptake.
- No significant correlation was found in healthy controls.
Takeaway
In Parkinson's disease, problems in the brain and heart are connected, showing that both are affected by similar issues.
Methodology
The study used FP-CIT SPECT and MIBG scintigraphy to assess degeneration in 95 Parkinson's patients and 20 healthy controls.
Potential Biases
Potential bias due to the exclusion of patients with other conditions affecting myocardial uptake.
Limitations
The study did not account for the effects of antiparkinsonian medications on imaging results.
Participant Demographics
95 patients with idiopathic Parkinson's disease, mean age 59 years; 20 healthy controls aged 37-74 years.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website